No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug similar to the diabetes drug Ozempic and the weight-loss drug Wegovy—last ...
Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...
End of Period Subscribers of 3.7 millionRevenues of $192.9 millionGross margin of 67.1%; adjusted gross margin of 69.1%Operating Loss of $39.0 million; adjusted operating income of $35.7 million NEW ...
8 Rebels fell 29-26 to No. 10 LSU in overtime in the Magnolia Bowl in Baton Rouge, handing a team with playoff expectations before the season its second loss through seven weeks. Tigers ...
The win shows that Georgia may very well be the best team in the Bowl Subdivision despite last month’s loss at Alabama ... been one of the most consistent programs in the Group of Five.